ALEXANDRA STEWART: Open Payments
NPI 1558736603 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 76 payments from 20 companies in 2025. Trend: 2023 $894 · 2024 $2,023 · 2025 $1,736
Food & beverage: $1,641Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $387 |
| Novartis Pharmaceuticals Corporation | 7 | $225 |
| GENZYME CORPORATION | 6 | $219 |
| ABBVIE INC. | 7 | $168 |
| Lilly USA, LLC | 5 | $130 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| PFIZER INC. | 5 | $81 |
| Incyte Corporation | 3 | $70 |
| UCB, Inc. | 2 | $51 |
| Amgen Inc. | 2 | $41 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, TALTZ, OPZELURA, CIBINQO, COSENTYX, Bimzelx.
Industry payments across VA — which companies pay providers there.
